Where does Université Laval rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Université Laval ranks #3,052 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Université Laval hold?

Université Laval holds 125 US utility patents granted between 2015 and 2025, spanning 100 technology areas.

What is Université Laval's Innovation Score?

Université Laval has an Innovation Score of 57.0 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Université Laval focus on?

Université Laval's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 36 patents, ranking #522 of 6,058 assignees active in that subclass. Grants appear in 100 CPC subclasses total.

Is Université Laval's patent grant rate increasing or decreasing?

Université Laval's recent grant velocity is -16% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Université Laval's patents?

Université Laval's patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Université Laval patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Université Laval

USPTO PatentsView assignee record - 125 granted patents across 100 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Université ranks #3,052 of 49,997 tracked US assignees by granted-patent volume, with 125 patents across 100 technology areas.

#3,052
of 49,997 US assignees by volume: Top 6%
by Innovation Score (57.0/100): 16.2
avg claims per patent: -16%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3052 · Foreign Corporation #3,052 · 125 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 125 grants
TOP-DECILE #3,052/49,997
PHOTO-FINISH SimpliSafe
CPC-WIDE A61P · 100 areas
INNOV-PAR 57.0/100
CLAIMS-RICH 16.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -16% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: SimpliSafe, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Université’s 57.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.7 pts (29%) Velocity 5.5 pts (10%) Breadth 25.0 pts (44%) Claim depth 9.7 pts (17%)

Qualcomm Incorporated · highest

85
Elekta · near

57
Technische UNIVERSIT… · near

57
Joled · near

57
NHK Spring · near

57
Université Laval · this assignee

57
3D Lighting… · lowest

7

What this shows Université's Innovation Score is 57.0/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Université?

Each dot is one of Université’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Université’s own 16.2 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Université vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Université's grant cadence moved

Between 2020–2024, Université Laval received 51 grants versus 61 in 2015–2019 (-16% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2017 at 18 grants and bottomed in 2023 at 4. Lead class A61P accounts for 28.8% of the portfolio across 100 subclasses. Volume neighbours: SKC Co., Ltd. (#3,048) and Acceleron Pharma Inc. (#3,056).

Université's three-year grant acceleration

From 2019–2021 to 2022–2024, Université Laval moved from 35 to 29 grants (0.83x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,722. See the growth leaderboard.

SKC

125
Simplisafe

125
Stichting Imec Ne…

125
UCL Business

125
V-nova Internatio…

125
Wm Wrigley Jr

125
Université Laval ◀

125
ASM Technology Si…

124
Acceleron Pharma

124

What this shows Université holds 125 patents at rank #3,052, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Université

By rank, the assignees closest to #3,052 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Université's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Université, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Université ranks #522 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

NHK Spring Co., Ltd. 57 Joled Inc. 57 Technische UNIVERSITÄT Berlin 57 Elekta Limited 57

Similar claim depth

Nearest assignees by average claims per patent (16.2 here).

Materialise N.V. 16.2 avg Powermat Technologies Ltd. 16.2 avg BAE Systems Information and Electronic Systems Integration Inc. 16.2 avg Tetra Technologies, Inc. 16.2 avg

Université's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Université Laval patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	4.8%
2016	10	8.0%
2017	18	14.4%
2018	14	11.2%
2019	13	10.4%
2020	13	10.4%
2021	9	7.2%
2022	14	11.2%
2023	4	3.2%
2024	11	8.8%
2025partial year	13	10.4%

Which technologies does Université Laval patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 36

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 35

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 26

G02B - Optical Elements, Systems OR Apparatus 19

C07K - Peptides 16

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

C07D - Heterocyclic Compounds 10

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 9

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 9

A61B - DIAGNOSIS; SURGERY; Identification 9

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 6

G06T - Image Data Processing OR Generation, IN General 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

C07C - Acyclic OR Carbocyclic Compounds 4

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 4

Top 15 of 100 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Université Laval's patent record in context - here's where to go next.

Université Laval's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 28.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,052 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Université Laval against SKC Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.